Canada markets closed

Janux Therapeutics, Inc. (JANX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
47.39+0.29 (+0.62%)
At close: 04:00PM EDT
47.00 -0.39 (-0.82%)
After hours: 04:42PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-58,293
-58,293
-63,059
-32,672
-6,784
Depreciation & amortization
1,955
1,955
841
113
13
Stock based compensation
20,005
20,005
17,203
6,910
72
Change in working capital
-6,554
-6,554
4,276
8,842
389
Accounts receivable
-
-
0
8,000
-8,000
Accounts Payable
277
277
-294
2,139
14
Other working capital
-52,425
-52,425
-49,367
-18,458
-4,369
Other non-cash items
-
-
-
-
1,941
Net cash provided by operating activites
-50,575
-50,575
-42,922
-16,976
-4,369
Cash flows from investing activities
Investments in property, plant and equipment
-1,850
-1,850
-6,445
-1,482
-
Purchases of investments
-317,344
-317,344
-294,389
-473,626
0
Sales/Maturities of investments
278,000
278,000
359,100
134,145
0
Net cash used for investing activites
-41,194
-41,194
58,266
-340,963
0
Cash flows from financing activities
Common stock issued
56,530
56,530
0
204,167
0
Net cash used privided by (used for) financing activities
59,548
59,548
500
386,524
11,524
Net change in cash
-32,221
-32,221
15,844
28,585
7,155
Cash at beginning of period
52,242
52,242
36,398
7,813
658
Cash at end of period
20,021
20,021
52,242
36,398
7,813
Free Cash Flow
Operating Cash Flow
-50,575
-50,575
-42,922
-16,976
-4,369
Capital Expenditure
-1,850
-1,850
-6,445
-1,482
-
Free Cash Flow
-52,425
-52,425
-49,367
-18,458
-4,369